DMPA self-administration can improve contraceptive access, continuation, and autonomy

Commentary on the Burke et al. article Effect of self-administration versus provider-administered injection of subcutaneous depot medroxyprogesterone acetate on continuation rates in Malawi: a randomised controlled trial published in Lancet Global Health.

Institutional author(s): Planned Parenthood
Individual author(s): Julia E. Kohn
Publication date: March, 2018

DMPA self-administration can improve contraceptive access, continuation, and autonomy

Categories

Tags